** Shares of diagnostic company DermTech DMTK.O sink more
than 57% to 14 cents premarket
** Co filed for Chapter 11 bankruptcy protection and plans
to sell substantially all of its assets
** Court filing shows DMTK has listed estimated assets and
liabilities in range of $50 mln-$100 mln
** DMTK also cut 15 jobs, could reduce more in the future
** Co intends to continue its laboratory operations and
processing orders for its cancer diagnostic tests during
bankruptcy proceedings
** As of last close, stock has already tumbled 81% YTD
(Reporting by Pratik Jain in Bengaluru)
((Pratik.Jain@thomsonreuters.com))